Reviewed by Peptide Treatments Medical Advisory Board (Medical Advisory Board)
Insulin: Evidence Summary
Evidence summary for Insulin across studied indications. Each indication is graded using our evidence tier system based on the quality and quantity of available clinical data.
Back to Insulin overview| Indication | Evidence Tier | Trial Count | Summary |
|---|---|---|---|
| Type 1 diabetes | Tier A | 200 | Life-sustaining; DCCT showed 76% retinopathy reduction with intensive control |
| Type 2 diabetes | Tier A | 300 | UKPDS showed 12% reduction in diabetes-related death |
| Diabetic ketoacidosis | Tier A | 50 | Standard of care — IV insulin infusion protocol |
| Hyperkalemia | Tier A | 20 | IV insulin + glucose is standard of care for acute hyperkalemia |